Cannabinoid API's for licensed pharmaceutical formulation.

Cilo Cybin manufactures GMP cannabinoid Active Pharmaceutical Ingredients including THC distillate, CBD distillate, CBD isolate, THCV, CBN isolate, and CBG isolate.

This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.

Cilo Cybin's API portfolio is built around controlled cannabinoid refinement, GMP traceability, and formulation-ready inputs for licensed partners.

Cilo Cybin's API portfolio is designed for buyers who need more than a cannabinoid commodity. The value sits in GMP manufacturing discipline, controlled refinement, analytical release, batch traceability, and documentation that can stand up to partner and regulatory review.

Use this catalogue to compare selected THC, CBD, CBG, CBN, CBC, THCV, CBT, and CBD-V inputs by product family, physical format, potency target, and intended manufacturing use across oils, capsules, edibles, topicals, compounding, and partner-defined product systems.

88-92% THC with 3-4% CBG and 1-2% CBN; clear to amber refined oil.

98%+ THC specification target; highly refined clear to pale amber oil.

43-58% CBD with 15%+ minor cannabinoids; free-flowing amber oil.

≥99% CBD specification target; off-white crystalline powder.